#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Malignant oligodendroglioma Oesophageal adenocarcinoma Chronic inflammatory demyelinating polyradiculoneuropathy Leber's congenital amaurosis Familial amyotrophic lateral sclerosis Hypochondroplasia Deafness Ewing's sarcoma metastatic Glioma Vitamin B12 deficiency Keratosis follicular Liposarcoma Meningitis meningococcal Metastases to peritoneum Retinal artery occlusion More trials…

    Learn about Rare Diseases

    Mastocytosis – Trials in Disease Waldenstrom’s macroglobulinaemia refractory – Treatment Waldenstrom’s macroglobulinaemia recurrent Langerhans’ cell histiocytosis Congenital nephrogenic diabetes insipidus – Treatment Combined immunodeficiency – Treatment Mucopolysaccharidosis III – Diagnostics Phenylketonuria – Diagnostics Rhabdomyosarcoma – Trials in Disease Uterine leiomyosarcoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Degarelix Lasmiditan TRIGLYCERIDES MEDIUM CHAIN Bendamustine Hydrochloride HUMAN FIBROBLASTS LY3841136 SODIUM Gsk3739937 INDAPAMIDE HEMIHYDRATE ROPINIROLE Elacestrant Dihydrochloride Daridorexant BUDOPRUTUG Canis Familiaris (553) Prilocaine Evg321 Glibenclamide Blu-263 Phosphate Naloxegol Oxalate Ecoo4 Siremadlin More therapies…

    Learn about Your Condition

    Vertigo Radius fracture Connective tissue disorder Alcohol use disorder Primary hyperaldosteronism Arrhythmia Staphylococcal bacteraemia Leukaemia Radicular pain Cholestatic pruritus Hypercholesterolaemia Renal cancer recurrent Cervix carcinoma stage IV Pituitary tumour benign Breast cancer stage II More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. IRCCS Humanitas Research Hospital

IRCCS Humanitas Research Hospital

Via Alessandro Manzoni 56, Rozzano, 20089, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Trastuzumab Deruxtecan with or without Pertuzumab for Patients with HER2-positive Metastatic Breast Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Docetaxel
    • Paclitaxel
    • Pertuzumab
    Belgium Denmark France Germany Hungary Italy +3

  • Study on the Effectiveness and Safety of ND0612 Infusion vs. Oral Treatment for Parkinson’s Disease Patients with Motor Fluctuations

    Not recruiting

    3 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • Carbidopa
    • Levodopa
    Austria Belgium Czechia France Italy Poland +3

  • Study of Tisagenlecleucel for Adults with Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Primary mediastinal large B-cell lymphoma
    • High-grade B-cell lymphoma
    • Diffuse large B-cell lymphoma
    Investigated Drugs:
    • Melphalan
    • Carmustine
    • Bendamustine Hydrochloride
    Austria France Germany Italy The Netherlands Norway +1

  • Study on Monitoring Adalimumab for Maintaining Disease Control in Adults with Rheumatoid Arthritis

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Adalimumab
    Austria Italy Norway Romania Sweden

  • Study on the Effectiveness and Safety of Guselkumab and Golimumab for Patients with Moderate to Severe Crohn’s Disease

    Not recruiting

    2 1
    Investigated Drugs:
    • Golimumab
    • Guselkumab
    Austria Belgium Bulgaria Croatia Czechia Denmark +13

  • A Study of GEN1047 in Patients with Solid Tumors: First Time Use in Humans

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Neoplasm malignant
    Investigated Drugs:
    • Gen1047
    Belgium Denmark France Italy The Netherlands Poland +1

  • Study on Baxdrostat and Dapagliflozin for Adults with Chronic Kidney Disease and High Blood Pressure

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Baxdrostat
    • Dapagliflozin
    Belgium Bulgaria Czechia Denmark France Germany +9

  • Study of Imetelstat in Patients with Low or Intermediate Risk Myelodysplastic Syndromes (MDS) Refractory to Erythropoiesis-Stimulating Agents

    Not recruiting

    4 1 1
    Investigated Drugs:
    • Imetelstat Sodium
    Belgium Czechia France Germany Italy The Netherlands +2

  • Study on the Effects of Guselkumab and Golimumab for Patients with Moderate to Severe Ulcerative Colitis

    Not recruiting

    2 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Golimumab
    • Guselkumab
    Austria Belgium Bulgaria Croatia Czechia Denmark +14

  • Study Comparing Trastuzumab Deruxtecan and Trastuzumab Emtansine for Patients with Advanced HER2-Positive Breast Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer metastatic
    • HER2 positive breast cancer
    Investigated Drugs:
    • Trastuzumab Deruxtecan
    • Trastuzumab Emtansine
    Belgium France Italy Spain
Previous Page
1 … 52 53 54 55 56 … 69
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!